Immunovant, Inc. (NASDAQ:IMVT) has 193 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 16,990,754 | 2,261,199 | 15.35% | $431,904,967.00 |
| FMR LLC | 31 Dec, 2025 | 16,947,888 | -42,866 | -0.25% | $420,985,547.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 11,526,971 | 1,798,126 | 18.48% | $293,015,603.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 11,526,971 | 0 | 0.00% | $286,329,960.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 7,779,314 | 952,504 | 13.95% | $197,750,162.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 6,574,497 | 516,281 | 8.52% | $163,310,512.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 6,058,216 | 319,980 | 5.58% | $153,999,851.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 5,747,155 | -88,845 | -1.52% | $146,092,680.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 5,633,862 | 469,164 | 9.08% | $143,214.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 5,457,881 | 0 | 0.00% | $138,739,335.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 5,457,881 | 0 | 0.00% | $135,573,764.00 |
| Alpine Global Management, LLC | 31 Dec, 2025 | 5,254,384 | -255,078 | -4.63% | $133,541,022.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 4,961,936 | 2,720,183 | 121.34% | $126,132,414.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,846,385 | 2,887,359 | 147.39% | $123,195,151.00 |
| State Street Corp | 31 Dec, 2025 | 4,537,929 | 751,003 | 19.83% | $112,722,156.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 4,457,988 | 2,797,055 | 168.40% | $110,736,422.00 |
| Morgan Stanley | 31 Dec, 2025 | 3,876,877 | -969,508 | -20.00% | $96,301,649.00 |
| State Street Corp | 31 Dec, 2025 | 3,786,926 | 894,308 | 30.92% | $96,263,659.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Dec, 2025 | 3,704,905 | 3,704,905 | 0.00% | $92,029,840.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 3,620,050 | 3,620,050 | 0.00% | $89,922,042.00 |